You are here: Industry Insights > Moderna

News List

Moderna commences trial of COVID-19 vaccine in children expresspharma
March 17, 2021
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to less than 12 years.
First participants dosed in Phase 1 study evaluating mRNA-1283, Moderna's next generation COVID-19 vaccine worldpharmanews
March 16, 2021
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 1 study of mRNA-1283, the Company's next generation COVID-19 vaccine candidate.
Antibodies generated by COVID-19 vaccines less effective against some variants: US Study expresspharma
March 15, 2021
According to the scientists, the two strains first described in Brazil and Japan were five to seven times more resistant, compared to the original SARS-CoV-2 virus lineage from Wuhan, China.
First patients receive Moderna’s modified COVID-19 vaccine candidates europeanpharmaceuticalreview
March 12, 2021
Moderna has begun testing two new mRNA COVID-19 vaccines, one specifically targeting the B.1.351 variant and the other a multivalent candidate.
A single vaccine dose is sufficient for immunity in COVID-19 survivors, finds study europeanpharmaceuticalreview
March 12, 2021
New research shows a second COVID-19 vaccine dose may be unnecessary in individuals previously infected with SARS-CoV-2 and needlessly exposes individuals to higher rates of adverse effects.
Pfizer interested in producing vaccine in India if speedy clearance, export freedom assured: Reports expresspharma
March 11, 2021
Pfizer has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
COVID-19 booster shots more likely as variants could cut efficacy of vaccines: GlobalData expresspharma
March 10, 2021
Pfizer and Moderna are already working on developing booster shots for their vaccines to improve their effectiveness against the B.1.351 strain.
Moderna signs supply deal with Philippines for 13 mn doses of COVID-19 vaccine expresspharma
March 08, 2021
Moderna announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna.
Moderna and IBM Plan to Collaborate on COVID-19 Vaccine Supply Chain and Distribution Data Sharing prnewswire
March 05, 2021
Moderna and IBM announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management.
Moderna sends South Africa variant-specific vaccine for clinical study pharmatimes
February 26, 2021
Moderna has shipped doses of a variant-specific vaccine candidate against the COVID-19 variant first discovered in South Africa, otherwise known as B.1.351, to the US National Institutes of Health (NIH) for clinical study.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page